$700 Million. If This Is First, Your Panel Has a Price.

PitchBook put about $700 million on Wood Smith Henning & Berman. August 18, 2026. Eighteen times $38.2 million. The people who pay those lawyers already set the rate. Tyson & Mendes, another national insurance-defense shop, was already shopping in July. If this one clears, the rest of the panel has a number.

That is the story. Not the four owners. Not the London office. Not the sale-memo adjectives. What happens to a Fortune 500 claims department, and to an insurance company that still staffs its injury book through a roster of independent defense firms, if a $700 million letter of intent is the first of ten.

The arithmetic does not care about the letterhead. PitchBook's people familiar said billing rates are typically constrained by insurance companies and margins can be modest, so the levers are technology, offshoring, and centralizing operations. Eighteen times on a shop that cannot raise its own rates is a bet on how the work gets done, not on a higher rate. The next dollar comes from a more efficient file, a wider platform, and the data that file produces. The tool that fills the productivity gap is AI. You cannot say that without saying what it hits. A defense shop still gets paid for time. Every hour a model takes off a file is an hour that invoice loses, unless the firm has already left the hour behind or takes the surplus in volume. Private equity cannot underwrite eighteen times on a practice that bills time and then celebrate the software that deletes time. The return only works if AI does work that used to be hours, the rate stays flat, and the platform takes more of the book. If that bet works once, it gets copied.

The closest profession already ran the tape. In August 2021, EisnerAmper took TowerBrook Capital Partners and split the licensed audit practice from the rest, the same wall WSHB is reported to be using. Allan Koltin later counted twelve accounting firms that took private-equity money after that first one. EisnerAmper itself made about fourteen acquisitions in the next three years. By March 2024, New Mountain was in Grant Thornton, the seventh-largest firm in the country, $2.4 billion of revenue. Hellman & Friedman was in Baker Tilly. Five of the top twenty-six had sold a stake in under three years. The first deal was not the story. The first deal was permission.

The first deal was not the story. The first deal was permission.

Charlesbank, the name Above the Law put on WSHB, already owns that template. On July 11, 2024, it put institutional capital into Aprio. Aprio LLP kept the licensed attest work. Aprio Advisory Group LLC took everything else. Aprio had already completed twenty-eight combinations since 2016. Michael Choe, Charlesbank's CEO, said the firm was building "a truly exceptional integrated professional services platform." That sentence does not belong to one Atlanta accounting shop. It is the sentence you write when the first deal is supposed to become a category.

The companies that pay WSHB already live with the second analogy, and they live with it on the same claim file. Sedgwick administers the claim before the defense firm ever opens it. Carlyle bought in 2018 at $6.7 billion. In November 2024, Altas Partners led a billion-dollar recap and Sedgwick's enterprise value was $13.2 billion. Same company. Same claims book. One more PE hand. Gallagher Bassett kept buying specialty units on the public-company side of the same street. The injury file already has a private-equity operating system on the TPA side. What it has not had, at this size, is a private-equity operating system on the counsel side. A platform in WSHB's class would be the last layer.

Healthcare is the caution, not the prediction. A BMJ systematic review of private-equity ownership in care found the most consistent result was higher cost to patients and payers. Quality was mixed to harmful. Staffing often shifted toward a cheaper skill mix. When the payer still set the rate, the return came from volume and from who sat in the room. Congress banned surprise billing. Envision, a PE-backed emergency staffing company, went into bankruptcy. A 2024 Senate letter on Envision and TeamHealth asked what the next lever would be once that one was dead. For a hospital, it was fewer physicians on the shift. For a defense platform that cannot raise rates, the live question is cleaner: does the work get better, or only cheaper. That is a question for the category, not a charge against one shop.

Dental ran the roll-up until affiliation stopped being a side door and started being the market. Platforms buy practices the way a defense MSO would buy shops: add-ons, not new platforms. Insurance still writes the fee schedule. The independent office becomes the exception. That is what "first of many" looks like when the customer already holds the pricing pen.

First principles, then, for the company that relies on these firms.

One. A multiple that cannot come from rate has to come from how the file is run. Fewer hours. Lower unit cost. More of your book on one platform. AI is how you get the fewer hours without losing the work, and how you run more files through the same lawyers. That only pays the 18x if the engagement is no longer a clock. As long as a firm bills the hour, the model that does the memo collides with its own revenue line. The clean version is the opposite: the hour recedes, AI fills the gap, the invoice stays flat or becomes a fee, and the platform can take more of the book. A claims department that still manages counsel by the hour will miss that, or it will keep paying for hours the software already did. A department that manages counsel by outcome, cycle time, and who actually touched the file will see it.

Two. The first platform is a hunting license. Tyson & Mendes is already in the waiting room. If WSHB clears near eighteen times, every founder-owned national defense firm has a price, because four partners can sell a shop that a two-thousand-lawyer partnership cannot. Accounting did not stop at EisnerAmper. It went through the top ten. Defense will not stop at Los Angeles if the multiple holds.

Three. Panel concentration is the thing a Fortune 500 legal department spent twenty years building leverage against. You split the book across six shops so no one owns your outcomes, your rates, or your data. Three of those shops becoming one operating system is not six letterheads. It is one dashboard. Sedgwick already showed what scale does to the claims factory. A defense MSO that adds two more national shops is the same move, one layer down the file.

Four. The data pipe is the asset the 18x is actually underwriting. Venue history, payout curves, counsel scores, medical-bill patterns: that is the book a defense shop builds by running other people's claims. PitchBook's investor thesis is that insurance-defense mandates tend to remain with the firm. If the mandate stays and the data from three former competitors now sits in one MSO, the companies that paid those files funded a training set they do not control. You already lived a version of this when the TPA stacked your claims data. This is that stack, on the lawyer side.

Five. Independence becomes a contract term, not a professional courtesy. Rule 5.4 is why the lawyers keep the license. Lawfuel's sentence is the one that lasts: an MSO is not a universal safe harbor. The client question is simpler. Who can fire the lawyer on this file. Who sets the staffing. Who sees the book. If three panel firms answer those questions from the same services company, write it into the engagement letter before the second close, not after the fifth.

What this does not mean. It does not mean Big Law goes first. It does not mean the first PE deal in American law. Plaintiff shops already sold the back office. Orion signed John Foy in June. It does not mean Charlesbank has bought WSHB. PitchBook's body is a letter of intent. Above the Law and the FT-citing desks named Charlesbank. Both sides have been silent. Nobody has announced a close.

What it does mean, if the LOI holds, is narrower, and it changes the market a company still treats as a panel. Defense litigation has been the last fragmented layer on an injury file that is otherwise already industrialized. The TPA is a platform. The medical bill is a platform. The specialty risk, as of August 13, has a $4 billion bid on the exchange it runs through. The lawyer was the part that still looked like a partnership. $700 million is the first time a defense shop this size has been given a private-equity number. The future of the panel is not a better brief from a worse firm. It is fewer owners of the operating system, AI doing work the hour used to sell, a flat rate on a more efficient file, and a data pipe the companies that paid those files will want a say in.

Ask the panel in writing now, while there is still more than one of them. Does an investor hold an economic interest. Who sets the management fee. Who owns the litigation data generated on your matters. Are you still buying hours, or the file. What happens to this file if the shop next to you sells.

If WSHB clears, those questions stop being hypothetical. They become the spec for the next decade of defense work.

Sources: PitchBook; Above the Law; Law.com; Tyson & Mendes / Yahoo; Aprio; CFO Brew; CFO Brew; Sedgwick; BMJ; Senate HSGAC; Lawfuel.